AMGN

Amgen Names Steven K. Galson, Senior Vice President, Global Regulatory Affairs And Safety

[PR Newswire] – THOUSAND OAKS, Calif., May 12, 2014 /PRNewswire/ — Amgen (AMGN) today announced the appointment of Steven K. Galson, M.D., M.P.H., to the position of senior vice president, Global Regulatory Affairs and Safety, effective May 19. Galson w moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is […]

Amgen

moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]

Amgen And AstraZeneca Announce Positive Results From Phase 3 Study Of Brodalumab (AMG 827) In Patients With Moderate-to-Severe Plaque Psoriasis

[PR Newswire] – THOUSAND OAKS, Calif. and LONDON, May 9, 2014 /PRNewswire/ — Amgen (AMGN) and AstraZeneca today announced that the Phase 3 AMAGINE-1TM study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and s moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, […]

AMGEN INC Financials

moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]